J. Brotherton

VCS Foundation VCS Population Health
Professor Julia Brotherton is a public health physician and Medical Director of Population Health, VCS Foundation, Melbourne, Australia. She is Professor of Cancer Prevention Policy and Implementation at the Melbourne School of Population and Global Health, University of Melbourne, Professorial Fellow at the National Centre for Immunisation Research and Surveillance and Visiting Professor, University of Malaya. She is a medical graduate from the University of Newcastle, has a MPH and PhD from the University of Sydney, and holds a Fellowship in Public Health Medicine. Julia was Medical Director of the former National HPV Vaccination Program Register and for over fifteen years has been involved in research and policy development informing the implementation and evaluation of HPV vaccination programs. She was a lead investigator in Australian research demonstrating the world’s first evidence of dramatic declines in both HPV infections and pre-cancerous cervical lesions in young women post- vaccination. She has 220 publications to date and is a member of the WHO Director General's Expert Advisory Group on Cervical Cancer Elimination, CHIC’s global HPV Vaccine Council, and the Single Dose HPV Vaccination Evaluation Consortium. Julia cochairs the SUCCESS ECHO program, an Indo Pacific region community of practice focused on WHO’s cervical cancer elimination strategy.

Author Of 10 Presentations

PAN AMERICAN HEALTH ORGANIZATION (PAHO) GUIDANCE FOR EVALUATING THE IMPACT OF HPV VACCINATION PROGRAMS (ID 580)

Presenter
Lecture Time
07:10 AM - 07:15 AM

HOW DOES THE TRANSITION TO PRIMARY HPV SCREENING IMPACT COLPOSCOPY: FINDINGS FROM THE STAKEHOLDERS OPINIONS OF RENEWAL IMPLEMENTATION AND EXPERIENCES STUDY (STORIES). (ID 70)

Presenter
Lecture Time
06:35 AM - 06:40 AM

Chair Introduction (ID 986)

Presenter
Lecture Time
12:00 PM - 12:02 PM

ACCEPTABILITY OF AUSTRALIA'S NEW HPV-BASED CERVICAL SCREENING PROGRAM: PERSPECTIVES OF KEY IMPLEMENTATION STAKEHOLDERS (ID 223)

Presenter
Lecture Time
06:45 AM - 06:50 AM

Moderated panel discussion (ID 1180)

Lecture Time
06:47 AM - 07:27 AM

MONITORING AUSTRALIA’S PROGRESS TOWARDS THE ELIMINATION OF CERVICAL CANCER AS A PUBLIC HEALTH PROBLEM: THE DEVELOPMENT AND REPORTING OF 11 KEY INDICATORS (ID 299)

Presenter
Lecture Time
11:58 AM - 12:10 PM

LONGITUDINAL OUTCOMES FROM THE FIRST PHASE OF THE COMPASS TRIAL IN AUSTRALIA: RCT OF PRIMARY HPV VS CYTOLOGY SCREENING IN AN HPV-VACCINATED POPULATION (ID 956)

Presenter
Lecture Time
06:39 PM - 06:51 PM

STAKEHOLDER PERSPECTIVES ON THE IMPLEMENTATION OF THE SELF-COLLECTION PATHWAY IN AUSTRALIA’S CERVICAL SCREENING PROGRAM (ID 148)

Presenter
Lecture Time
06:40 AM - 06:45 AM

The example of Australia: 11 key indicators to monitor progress towards elimination (ID 1179)

Presenter
Lecture Time
06:40 AM - 06:47 AM

THE EXPERIENCE OF UNDER-SCREENED AND NEVER-SCREENED PARTICIPANTS USING CLINICIAN-SUPPORTED SELF-COLLECTION CERVICAL SCREENING IN THE AUSTRALIAN NATIONAL CERVICAL SCREENING PROGRAM (ID 291)

Presenter
Lecture Time
07:00 AM - 07:05 AM

Presenter of 4 Presentations

Moderated panel discussion (ID 1180)

Lecture Time
06:47 AM - 07:27 AM

MONITORING AUSTRALIA’S PROGRESS TOWARDS THE ELIMINATION OF CERVICAL CANCER AS A PUBLIC HEALTH PROBLEM: THE DEVELOPMENT AND REPORTING OF 11 KEY INDICATORS (ID 299)

Presenter
Lecture Time
11:58 AM - 12:10 PM

The example of Australia: 11 key indicators to monitor progress towards elimination (ID 1179)

Presenter
Lecture Time
06:40 AM - 06:47 AM

Chair Introduction (ID 986)

Presenter
Lecture Time
12:00 PM - 12:02 PM

Moderator of 2 Sessions

Session Type
Workshop
Date
Mon, Nov 15, 2021
Session Time
12:00 PM - 01:30 PM
Chair(s)
Session Icon
Live
Session Type
Clinical Research Oral
Date
Thu, Nov 18, 2021
Session Time
06:00 PM - 07:00 PM
Session Icon
Pre-Recorded with Live Q&A